ACHV Achieve Life Sciences Inc
Company Analysis
Latest News
🔴 Achieve Life Sciences is trading 10% down today amid biotech sector weakness
Achieve Life Sciences is trading lower amid biotech sector weakness, at $6.27 (-10.04%). - XBI fell 2.06% during the regular session; the S&P 500 was down...
🔴 Achieve Life Sciences falls 5.9% — Biotech Sector Declines Amid Broad Market Rotation
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as represented by the XBI...
🟢 Achieve Life Sciences is trading 6.17% up in pre-market
Achieve Life Sciences is trading at $7.40, up 6.17% in pre-market; no clear company-specific catalyst has been identified. - The company’s news page shows no...
🔴 Achieve Life Sciences is trading 9.3% down in pre-market with no confirmed catalyst
Achieve Life Sciences is trading 9.3% down in pre-market at $6.35 on October 14, 2026, with no specific catalyst identified. - The previous close was $7.00. -...
🔴 Achieve Life Sciences is trading 5% down
Achieve Life Sciences is trading at $6.87, down 5.11%, with no confirmed October 5 company-specific catalyst. - Recent coverage centers on Benjamin Halladay...
🔴 Achieve Life Sciences is trading 5% down
Achieve Life Sciences is trading 5.05% down at $7.15; no confirmed company-specific news explains the October 2 decline. - Latest announcements were a CFO...
🟢 Achieve Life Sciences is trading 6% up in pre-market with no confirmed company-specific catalyst
Achieve Life Sciences is trading at $7.99, up 6.11% in pre-market, with no confirmed company-specific catalyst. - Broader U.S. indices were higher pre-market,...
Achieve Life Sciences Appoints Benjamin Halladay as New Chief Financial Officer
Achieve Life Sciences announced the appointment of Benjamin Halladay as its new Chief Financial Officer (CFO), effective October 5, 2026. Mr. Halladay will...
🔴 Achieve Life Sciences is trading 5% down — no company-specific catalyst identified
Achieve Life Sciences is trading at $7.68, down 5.07%; no company-specific announcement explained the October 1 decline. - Latest identified news was an...
🟢 Achieve Life Sciences is trading 7% up as catalyst remains unclear
Achieve Life Sciences is trading 6.76% higher at $8.21, with no confirmed company-specific announcement explaining the move. - Its latest identified company...
🔴 Achieve Life Sciences is trading 6.77% down in pre-market with no clear company-specific catalyst identified
Achieve Life Sciences is trading 6.77% lower at $7.30, with no clear company-specific announcement identified for September 25, 2026. - The decline contrasts...
🟢 Achieve Life Sciences is trading 5% up in pre-market amid broader risk-on sentiment
Achieve Life Sciences is trading at $8.40 (+5.26%), apparently amid broader risk-on sentiment. - No new company-specific announcement was identified for...
🟢 Achieve Life Sciences is trading 5% up today as U.S. equities rally
Achieve Life Sciences is trading 5.26% up now at $7.81 as U.S. equities rally. - The S&P 500 is up 0.91%, while the Nasdaq Composite is up 1.27%. - The...
🔴 Achieve Life Sciences is trading 5% down today as risk-off sentiment pressures equities
Achieve Life Sciences is trading at $8.05, down 5.12%, amid a weaker September 8, 2026 market backdrop, including risk-off sentiment, higher oil prices,...
Frazier Life Sciences Takes 7.4% Stake in Achieve, Backing Nicotine Treatment
Frazier Life Sciences Management L.P. purchased 7,614,836 shares of Achieve Life Sciences. This investment establishes a 7.40% ownership position in the...
🟢 Achieve Life Sciences is trading 5% up today despite weaker broader markets and biotech
Achieve Life Sciences is trading at $8.35, up +5.16%, though the specific reason for the intraday increase remains unclear. - No major company-specific...
venBio Partners Takes 5.75% Stake in Achieve Life Sciences, Eyeing 2027 Launch
venBio Partners LLC acquired 5,914,720 shares of Achieve Life Sciences. This investment represents a 5.75% stake in the biopharmaceutical company. The position...
🟢 Achieve Life Sciences rises 5.5% — Biotech Sector Gains Amid Broad Market Rally and Positive Sentiment
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, represented by the XBI ETF, is...
🟢 Achieve Life Sciences is trading 5.5% up in pre-market without a clear company-specific catalyst
Achieve Life Sciences is trading 5.51% up now at $8.38 after no clearly reported company-specific catalyst emerged for August 25, 2026. - Latest material...
🟢 Achieve Life Sciences is trading 6% up in pre-market today amid a possible biotech sentiment rebound
Achieve Life Sciences is trading at $8.50 (+5.99%), with no new company-specific announcement dated August 21, 2026 identified. - The latest official listing...